NCT01007955View on ClinicalTrials.gov

Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Morbid ObesityInsulin ResistanceNon-Alcoholic Fatty Liver Disease
Trial Locations (1)

01655

UMass Memorial Medical Center, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT01007955 - Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery | Biotech Hunter | Biotech Hunter